The application of botulinum toxin in the treatment of overactive bladder

Justyna Wojcik, Aleksandra Obuchowska, Alicja Ozga, Arkadiusz Standyło




Urinary incontinence is an involuntary, decision-dependent urination that leads to partial or complete emptying of the bladder. The causes include overactive bladder syndrome, which is diagnosed on the basis of clinical symptoms, such as urgency to urinate, increased frequency of voiding, nocturia caused by increased reactivity of the detrusor muscle. Treatment of this condition includes, but is not limited to, pharmacotherapy, behavioral therapy, and pelvic floor exercises. It is also possible to use an innovative method of local injection of botulinum toxin into the bladder. It inhibits the release of acetylcholine, which results in the inhibition of the contractile activity of the detrusor muscle.

The aim of the study:       

            The purpose of the systemic review was to collect and analyze material of application of botulinum toxin in the treatment of urinary incontinence caused by overactive bladder.

Material and methods:

The work is a review of the literature on the use of botulinum toxin in the treatment of overactive bladder, published in 2002-2020.

Description of the state of knowledge:

The use of the described method gives long-lasting results compared to pharmacotherapy. In addition, it eliminates the side effects caused by drugs because the administration of drugs is reduced or discontinued. The use of botulinum toxin has many more benefits than simply improving the lives of people affected by urinary incontinence. When selecting the therapy, one should also pay attention to possible side effects resulting from the use of the described drug.


Intravesical administration by means of botulinum toxin cystoscopy is a modern, safe, effective and minimally invasive method of treating urinary incontinence, possible on an outpatient basis, allowing to improve the urodynamic parameters. Side effects are very rare. The botulinum toxin serotype A used in this method is the most studied serotype used for therapeutic purposes. The conducted research shows that over 90% of women reported a clinically significant improvement in sexual function after using the method.


urinary incontinence; botulinum toxin; overactive bladder

Full Text:



Coyne KS, Sexton CC, Irwin DE i in. Effects of an overactive bladder, urinary incontinence and other lower urinary tract symptoms on quality of life, productivity at work, sexuality, and emotional well-being in men and women: study results EPIC. BJU Int 2008; 101: 1388–1395

Teleman PM, Lidfelt J, Nerband C. et al. WHILA study group. Overactive bladder: Prevalence, risk factors and relation to stress incontinence in middle aged women. BJOG. 2004;111(6):600–4.

Morrison J, Steers WD, Brading AF. et al. Neurophysiology and neuropharmacology. Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. (2nd ed) 2002:86–163.

McGrouther CW, Donaldson MM, Thompson J. et al. Etiology of overactive bladder: A diet and lifestyle model for diabetes and obesity in older women. Neurourol Urodyn. 2012;31(4):487–95

Allahdin S & N. Oo (2012) An overview of treatment of overactive bladder syndrome in women, Journal of Obstetrics and Gynecology, 32: 3, 217-221

Pannek, J. Überaktive Blase – wann welche Therapie. Urologe 2017, 56:1532–1538

Brubaker L, Richter HE, Visco A, Mahajan S, Nygaard I, Braun TM . 2008. Refractory idiopathic urge urinary incontinence and botulinum A injection. Journal of Urology 180:217–222.

Anger JT, Weinberg A, Suttorp MJ, Litwin MS, Shekelle PG. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature. Journal of Urology 2010; 183: 2258–2264.

Jankowic J., Vuong K.D., Ahsan J. Comparison of efficacy and immunogenicity of orginal versus current botulinum toxin in cervical dystonia. Neurology 2003; 60: 1186.

Jankovic J., Gchwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995; 45: 1743–1751.

Brin M.F. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 1997; 6: 146–151

Simpson LL. 2004. Identification of the major steps in botulinum toxin action. Annual Review of Pharmacology and Toxicology 44:167–193

Linsenmeyer TA. Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review. J Spinal Cord Med. 2013;36(5):402-419.

Ziegelmüller, BK, Sommer, A. & Bauer, RM Toksyna botulinowa w pęcherzu nadreaktywnym. Urolog 59, 963-972 (2020)

Grosse J, Kramer G, Stöhrer M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005;47(5):653–9

Giannantoni A, Mearini E, Del Zingaro M, Porena M. Six-year follow-up of botulinum toxin A intradetrusotial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 2009;55(3):705–11

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska, EuroPub database, NLM Catalog Result - NCBI, BASE, Russian Sciences Index, Arianta.

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:


PBN Poland



Redaction, Publisher and Editorial Office

Publisher and Editorial Office
Department of Physical Culture,
Faculty of Earth Sciences and Spatial Management,
Nicolaus Copernicus University in Toruń, Poland
Address: Str. Lwowska 1, 87-100 Toruń, Poland

  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

RG Journal Impact: 0.18 *

*This value is calculated using ResearchGate data and is based on average citation counts from work published in this journal. The data used in the calculation may not be exhaustive.

RG Journal impact history

2020Available summer 2021
2018 / 20190.18

RG Journal impact over time

RG Journal impact

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski


Partnerzy platformy czasopism